People accessing alcohol and other drug (AOD) services are disproportionately affected by hepatitis C, yet many continue to face barriers to testing, treatment and ongoing care. AOD services and needle and syringe programs are uniquely positioned to change this, playing a critical role in Australia’s hepatitis C elimination efforts. 

Join colleagues from across the AOD and health sectors for a practical, interactive workshop focused on what works in real-world settings. Through discussion, case examples and implementation-focused strategies, participants will explore how to strengthen hepatitis C prevention, testing, treatment and referral pathways within their own services. 

Whether you’re new to hepatitis C care or looking to improve existing approaches, this session will provide practical tools, current clinical updates and achievable service-level solutions that can be applied immediately in practice. You’ll also connect with others working towards better outcomes for people affected by hepatitis C.

This is an APSAD 2026 Conference Associated Event.

Date, Time & Venue:

• Date: Sunday 8 November 2026  
• Time: 3:30pm-5:00pm (AWST) 
• Venue: Esplanade Hotel Fremantle by Rydges, Walyalup, WA, Australia 

Learning Outcomes:

Participants will gain practical knowledge and skills to:

• Understand current hepatitis C transmission risks and harm reduction approaches
• Navigate testing, assessment, treatment, and referral pathways
• Communicate about hepatitis C in clear, supportive, and non-stigmatising ways
• Identify opportunities to strengthen hepatitis C responses within their service
• Support improved engagement, access to care, and continuity of treatment

Course Components:

• One 90-minute workshop
• Post course survey

Recommended Resources:

• Decision Making In Hepatitis C | ASHM
• Viral Hepatitis Mapping Project: National Report, Hepatitis C | ASHM
• ASHM Testing Portal | ASHM
• Beyond the C | ASHM
• Introduction to Hepatitis C Reflex Testing for GPs | ASHM
• Priority Populations for Hepatitis C Testing and Treatment | ASHM

CPD & Endorsement:

This activity may be suitable for self-claiming 1.5 CPD hours with your professional body. A statement of attendance will be provided for full attendees.

Funding:

This course is sponsored by AbbVie and Gilead. Sponsorship is provided in accordance with the ASHM’s Sponsorship Policy. ASHM does not endorse or promote any sponsor’s product or service.

Target Audience:

Clinical and non-clinical staff working across AOD care. This workshop is suitable for: 

• AOD clinicians and counsellors 
• Nurses and nurse practitioners 
• General practitioners 
• Peer workers 
• Care coordinators and case managers 
• Needle and syringe program (NSP) workers 
• Program leads, coordinators, and service managers 
• Other health professionals working with people affected by hepatitis C